A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

Condition(s) targeted: Asthma

Phase: N/A

Status: Recruiting

Sponsored by: GlaxoSmithKline

Official(s) and/or principal investigator(s):
GSK Clinical Trials, MD, Study Director, Affiliation: GlaxoSmithKline

The CATO population is a very well documented population during two years. During this study patients were treated according to the CATO algorithm, after that patient were treated according to the Dutch national (GINA derived) guidelines up to 6 years of follow-up. The purpose of this prospective follow-up study is to understand the long-term effects of treatment. Therefore the measurements done at baseline (CATO part 1) are repeated after 6 years in this CATO-population (CATO follow-up).

Official title: A Long Term Follow up Study for a Comparison of Stepwise Treatment of Asthmatic Children With Salmeterol/Fluticasone Propionate Combination Product (Seretide®) and/or Fluticasone Propionate (Flixotide®) Based on PD20 Methacholine and Symptoms or Based on Symptoms Only ("Children Asthma Therapy Optimal")

Study design: Natural History, Cross-Sectional, Defined Population, Retrospective/Prospective Study

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion criteria: Any subject who has given informed consent to participate in the primary CATO-study, and has met all the criteria required for randomisation into the clinical study may take part in this follow-up study. Exclusion criteria: For 4 weeks before visit 1 the subjects should not have experienced an acute asthma exacerbation requiring emergency room treatment or hospitalisation or use any oral/parental or depot corticosteroids. Subjects should not be pregnant.

GSK Clinical Trials Call Center, S GRAVENHAGE 2566ER, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, ROTTERDAM 3015GJ, Netherlands; Recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, SITTARD 6131BK, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, ZWOLLE 8011JW, Netherlands; Recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, VELDHOVEN 5504DB, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, BREDA 4818CK, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, GRONINGEN 9713GZ, Netherlands; Recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, ALKMAAR 1815JD, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, ALMERE 1315RA, Netherlands; Recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, AMSTERDAM ZUIDOOST 1105AZ, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, AMSTERDAM 1081HV, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, MAASTRICHT 6229HX, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, LEIDEN 2333ZA, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

GSK Clinical Trials Call Center, HILVERSUM 1213VX, Netherlands; Not yet recruiting
GSK Clinical Trials Call Center, Phone: 1-877-379-3718

Starting date: January 2007
Last updated: August 16, 2007